Trial intelligence / Profile preview

Truncal Ultrasound Guided Regional Anesthesia for Pediatric Pacemaker/AICD Implantation

NCT04184349Phase 4Completed

Sponsor
UTHealth Houston
Start
Oct 2020
Primary completion
Jun 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by UTHealth Houston. Primary endpoint: Total Narcotic Dose in Milligram Morphine Equivalents (MME) Per Kilogram at 48 hours. Started Oct 2020; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04184349.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04184349.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call